Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828048 · ClinicalTrials.gov registry record
International Registry for Intraductal Papillary Mucinous Neoplasma
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 290
- Enrollment target
NCT00828048: Completed study, sponsored by Mayo Clinic.
NCT00828048 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00828048 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
A centralized web-based database will be used to track patients with IPMN lesions of the pancreas to study natural history and risk factors for malignant transformation in this multi-center study.
Primary Outcome
Size and growth pattern of pancreas cysts, presence of mural nodules, development of solid tumor or malignancy will be tracked over time, based on imaging studies including EUS, MRI or CT as clinically indicated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2008-03 |
| Est. Completion | 2019-11-01 |
What the finished NCT00828048 record still lists
NCT00828048 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00828048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00828048 about?
NCT00828048 is a clinical study titled "International Registry for Intraductal Papillary Mucinous Neoplasma". A centralized web-based database will be used to track patients with IPMN lesions of the pancreas to study natural history and risk factors for malignant transformation in this multi-center study.
What is the current status of trial NCT00828048?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2008-03. Estimated completion is 2019-11-01.
Who is sponsoring clinical trial NCT00828048?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia